HomeTagsActemra

Actemra

Healthcare

U.S. FDA Grants Priority Review to Genentech’s Actemra for the Treatment of COVID-19 in Hospitalized Adults

Business Wire - April 4, 2022

Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application...

Biotechnology

Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-19

Globe Newswire - December 9, 2021

Roche Announced that the European Commission has extended the marketing authorisation for Actemra®/RoActemra® (tocilizumab) to include the treatment of COVID-19 in adults who are...